Egypt’s Ministry of Health and Population announced on Saturday that it issued 1,044,845 state-funded treatment approvals during the first quarter (Q1) of 2026, with a total value of LE8.5 billion.
According to a ministry statement, these approvals benefited 922,675 citizens across a diverse range of medical specialties.
These include haematology, spinal surgery, obstetrics and gynaecology, ear, nose and throat (ENT), internal medicine, general surgery, dermatology, neurology, orthopaedics, ophthalmology, immunology, urology, vascular surgery, interventional radiology, oncology, hepatology, maxillofacial surgery, endocrinology, rehabilitation, and dialysis.
The statement noted that these efforts are part of a broader government strategy to alleviate the financial burden on patients while ensuring the delivery of high-quality healthcare.
The ministry highlighted its increasing use of digital solutions, noting that 1,643 critical cases were assessed remotely via video conferencing, allowing clinical decisions to be made without requiring patients to travel.
Furthermore, 71,900 people with disabilities underwent medical assessments across 551 committees nationwide as part of the Integrated Services Card programme.
In addition, 76,406 applicants for the Takaful and Karama programme were examined, while 7,729 individuals were assessed for eligibility regarding tax- and customs-exempt vehicles.
The ministry reaffirmed its commitment to supporting citizens, particularly those on low incomes or living with disabilities, by streamlining access to state-funded treatment and ensuring the timely provision of essential services.
